Hsp90 inhibition aggravates adriamycin-induced podocyte injury through intrinsic apoptosis pathway.

[1]  J. Tu,et al.  HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma , 2017, Molecular Cancer.

[2]  J. Buchner,et al.  The HSP90 chaperone machinery , 2017, Nature Reviews Molecular Cell Biology.

[3]  C. Prodromou.  Mechanisms of Hsp90 regulation , 2016, The Biochemical journal.

[4]  J. Miner.  Podocyte biology in 2015: New insights into the mechanisms of podocyte health , 2016, Nature Reviews Nephrology.

[5]  H. Aburatani,et al.  IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis , 2016, Scientific Reports.

[6]  Matthew R Trendowski.  PU-H71: An improvement on nature's solutions to oncogenic Hsp90 addiction. , 2015, Pharmacological research.

[7]  J. Craig,et al.  Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children , 2015, Archives of Disease in Childhood.

[8]  M. Rastaldi,et al.  Podocyte injury and repair mechanisms , 2015, Current opinion in nephrology and hypertension.

[9]  J. Craig,et al.  Corticosteroid therapy for nephrotic syndrome in children. , 2015, The Cochrane database of systematic reviews.

[10]  K. Kaneko,et al.  Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes , 2015, World Journal of Pediatrics.

[11]  Soo-Hyun Park,et al.  Ubiquitination-dependent CARM1 degradation facilitates Notch1-mediated podocyte apoptosis in diabetic nephropathy. , 2014, Cellular signalling.

[12]  L. Paz-Ares,et al.  Inhibition of HSP90 molecular chaperones: moving into the clinic. , 2013, The Lancet. Oncology.

[13]  C. Lemaire,et al.  Hsp90 inhibition by PU-H71 induces apoptosis through endoplasmic reticulum stress and mitochondrial pathway in cancer cells and overcomes the resistance conferred by Bcl-2. , 2013, Biochimica et biophysica acta.

[14]  M. Sudol,et al.  Yes-associated Protein (YAP) Promotes Cell Survival by Inhibiting Proapoptotic Dendrin Signaling* , 2013, The Journal of Biological Chemistry.

[15]  O. Demidov,et al.  Inhibition of HSP70: a challenging anti-cancer strategy. , 2012, Cancer letters.

[16]  L. Barisoni.  Podocyte biology in segmental sclerosis and progressive glomerular injury. , 2012, Advances in chronic kidney disease.

[17]  D. Harris,et al.  Adriamycin nephropathy: A model of focal segmental glomerulosclerosis , 2011, Nephrology.

[18]  Jian Yu,et al.  1, 25-dihydroxyvitamin D3 decreases adriamycin-induced podocyte apoptosis and loss , 2010, International journal of medical sciences.

[19]  S. Lindquist,et al.  HSP90 at the hub of protein homeostasis: emerging mechanistic insights , 2010, Nature Reviews Molecular Cell Biology.

[20]  A. Melnick,et al.  Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models , 2009, Proceedings of the National Academy of Sciences.

[21]  S. Lindquist,et al.  Inhibiting the transcription factor HSF1 as an anticancer strategy , 2009 .

[22]  S. Shankland,et al.  Inducible rodent models of acquired podocyte diseases. , 2009, American journal of physiology. Renal physiology.

[23]  Matthias Merkenschlager,et al.  Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. , 2008, Journal of the American Society of Nephrology : JASN.

[24]  Kwanghee Kim,et al.  The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A , 2008, Nature Medicine.

[25]  K. Suszták,et al.  The Notch pathway in podocytes plays a role in the development of glomerular disease , 2008, Nature Medicine.

[26]  J. Massagué,et al.  Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer. , 2007, Nature chemical biology.

[27]  H. Müller-Hermelink,et al.  STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90α and β in multiple myeloma cells, which critically contribute to tumor-cell survival , 2007 .

[28]  S. Atkinson,et al.  Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. , 2005, Kidney international.

[29]  R. Lockshin,et al.  Caspase-independent cell deaths. , 2002, Current opinion in cell biology.

[30]  A. Bensman,et al.  A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening. , 2002, Journal of the American Society of Nephrology : JASN.

[31]  R. Portman,et al.  Changing patterns in the histopathology of idiopathic nephrotic syndrome in children. , 1999, Kidney international.

[32]  P. Carmeliet,et al.  Modification of kidney barrier function by the urokinase receptor , 2008, Nature Medicine.

[33]  B. Kaissling,et al.  CHAPTER 20 – Structural Organization of the Mammalian Kidney , 2008 .